Related Experiment Video
Updated: Jul 31, 2026

10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
[Familial multiple sclerosis in Canary Islands]
R Amela-Peris1, Y Aladro, M A Conde-Sendín
1Servicio de Neurología, Hospital de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
Revista De Neurologia
|December 2, 2004
Summary
Familial multiple sclerosis (MS) affects 13.9% of patients in the Canary Islands. This study found no clinical differences between familial and sporadic MS, suggesting they are not distinct entities.
Area of Science:
- Genetics
- Neurology
- Epidemiology
Context:
- Multiple sclerosis (MS) is a polygenic autoimmune disease with known familial aggregation.
- Understanding familial MS (fMS) prevalence is crucial for genetic and epidemiological insights.
Purpose:
- To determine the prevalence of familial MS (fMS) in a patient cohort from the Canary Islands.
- To analyze HLA DRB1 presence, clinical, and demographic characteristics in fMS compared to sporadic MS (sMS).
Summary:
- fMS prevalence was 13.9% in the Canary Islands cohort.
- The HLA DRB01*1501 allele was more frequent in familial cases.
- No intrafamilial concordance in clinical expression or phenotypic differences between fMS and sMS were observed.
Impact:
- The fMS prevalence aligns with other Mediterranean populations.
- Findings suggest fMS and sMS are not distinct clinical entities.
- This research contributes to the understanding of MS genetic epidemiology.
Related Concept Videos
Multiple Allele Traits
The Concept of Multiple Allelism
Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

